Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Coenzyme A (CoA) is an essential small molecule and ubiquitous biological cofactor involved in numerous metabolic pathways. It plays a central role in the synthesis and oxidation of fatty acids and the oxidation of pyruvate in the citric acid cycle. CoA acts as an acyl group carrier via its reactive thiol group to form thioester derivatives such as acetyl-CoA. These derivatives are crucial for energy production and biosynthetic processes including lipid metabolism and protein modification. CoA is synthesized from cysteine, pantothenate (vitamin B5), and ATP. In humans and other organisms, about 4% of cellular enzymes use CoA or its thioester forms as substrates[1][3][5][6]. Disruptions in CoA metabolism are linked to various diseases such as cancer, myopathies, cardiomyopathies, neurodegenerative disorders, diabetes, obesity and microbial infections[4][5][6]. While primarily considered a nutraceutical or investigational supplement rather than an approved pharmaceutical drug for specific indications in humans[1], it has been explored hypothetically for conditions like acne.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Coenzyme A.